Study on effects of sage in treatment of hyperlipidemic type 2 diabetic patients
- Conditions
- Diabetes mellitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201212112288N6
- Lead Sponsor
- Jahade Daneshgahi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
nclusion criteria: Iranian male and female type 2 diabetic outpatients, patients aged 40 to 60 years, patients with fasting serum glucose levels from 150 mg/dl to 200 mg/dl, patients with blood HbA1c levels from 7% to 9% despite taking two 5 mg glyburide tablets and two 500 mg metformin tablets every day, patients using two 5 mg glyburide tablets and two 500 mg metformin tablets every day, patients with fasting serum LDL levels from 100 mg/dL to 150 mg/dL and/or patients with fasting serum triglyceride levels from 200 mg/dL to 300 mg/dL. Exclusion criteria: Patients taking other anti-hyperglycemic and anti-hyperlipidemic agents, patients receiving insulin, patients with cardiac, renal, hepatic, hematological diseases, hypothyroidism, tachycardia, vertigo and seizure, patients with a history of gallstones or gall bladder surgery, patients using estrogen, steroid, beta-blocker and thiazide, pregnant women, women planning pregnancy, breast-feeding women.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting glucose serum level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Glycosylated hemoglobin blood level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum LDL-C level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum triglyceride level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).
- Secondary Outcome Measures
Name Time Method Serum total cholesterol level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum HDL-C level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum creatinine level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum SGOT level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).;Serum SGPT level. Timepoint: 3 months. Method of measurement: Medical laboratory (kit).